The Controversy over Hormone Replacement Therapy: Evaluating Related Risk of Breast Cancer and Other Diseases

The Controversy over Hormone Replacement Therapy: Evaluating Related Risk of Breast Cancer and Other Diseases
Author :
Publisher : Am Cncl on Science, Health
Total Pages : 18
Release :
ISBN-10 :
ISBN-13 :
Rating : 4/5 ( Downloads)

Book Synopsis The Controversy over Hormone Replacement Therapy: Evaluating Related Risk of Breast Cancer and Other Diseases by :

Download or read book The Controversy over Hormone Replacement Therapy: Evaluating Related Risk of Breast Cancer and Other Diseases written by and published by Am Cncl on Science, Health. This book was released on with total page 18 pages. Available in PDF, EPUB and Kindle. Book excerpt:


The Controversy over Hormone Replacement Therapy: Evaluating Related Risk of Breast Cancer and Other Diseases Related Books

The Controversy over Hormone Replacement Therapy: Evaluating Related Risk of Breast Cancer and Other Diseases
Language: en
Pages: 18
Authors:
Categories:
Type: BOOK - Published: - Publisher: Am Cncl on Science, Health

DOWNLOAD EBOOK

The Controversy over Hormone Replacement Therapy
Language: en
Pages: 18
Authors:
Categories:
Type: BOOK - Published: - Publisher: Am Cncl on Science, Health

DOWNLOAD EBOOK

Hormone Replacement Therapy and Breast Cancer
Language: en
Pages: 132
Authors: U. S. Department of Health and Human Services
Categories: Medical
Type: BOOK - Published: 2013-06-28 - Publisher: CreateSpace

DOWNLOAD EBOOK

In this systematic evidence review, we evaluate data on the relationship between the use of postmenopausal hormone replacement therapy (HRT) and the risk of bre
Menopause and Hormone Replacement
Language: en
Pages: 364
Authors: Hilary O. D. Critchley
Categories: Menopause
Type: BOOK - Published: 2004 - Publisher:

DOWNLOAD EBOOK

Hormone Replacement Therapy and Breast Cancer
Language: en
Pages:
Authors: Linda L. Humphrey
Categories:
Type: BOOK - Published: 2002 - Publisher:

DOWNLOAD EBOOK

OBJECTIVE: To evaluate and update the prior review evaluating the risk of breast cancer and breast cancer (BCA) death associated with the use of postmenopausal